BR112012014161A2 - theobromine-based pharmaceutical composition and a decongestant and its use in the treatment of cough - Google Patents

theobromine-based pharmaceutical composition and a decongestant and its use in the treatment of cough

Info

Publication number
BR112012014161A2
BR112012014161A2 BR112012014161A BR112012014161A BR112012014161A2 BR 112012014161 A2 BR112012014161 A2 BR 112012014161A2 BR 112012014161 A BR112012014161 A BR 112012014161A BR 112012014161 A BR112012014161 A BR 112012014161A BR 112012014161 A2 BR112012014161 A2 BR 112012014161A2
Authority
BR
Brazil
Prior art keywords
decongestant
theobromine
cough
treatment
pharmaceutical composition
Prior art date
Application number
BR112012014161A
Other languages
Portuguese (pt)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of BR112012014161A2 publication Critical patent/BR112012014161A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112012014161A 2009-12-14 2010-12-14 theobromine-based pharmaceutical composition and a decongestant and its use in the treatment of cough BR112012014161A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921805.8A GB0921805D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
PCT/GB2010/052085 WO2011073646A1 (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough

Publications (1)

Publication Number Publication Date
BR112012014161A2 true BR112012014161A2 (en) 2016-05-17

Family

ID=41667045

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012014161A BR112012014161A2 (en) 2009-12-14 2010-12-14 theobromine-based pharmaceutical composition and a decongestant and its use in the treatment of cough

Country Status (18)

Country Link
EP (1) EP2512464A1 (en)
JP (2) JP2013513651A (en)
CN (2) CN105816462A (en)
AU (1) AU2010332494B2 (en)
BR (1) BR112012014161A2 (en)
CA (1) CA2784214C (en)
CO (1) CO6541630A2 (en)
EC (1) ECSP12012132A (en)
GB (1) GB0921805D0 (en)
IL (1) IL220383A (en)
MX (1) MX343222B (en)
NZ (1) NZ600243A (en)
PE (1) PE20121537A1 (en)
RU (1) RU2564904C2 (en)
SG (2) SG10201408377QA (en)
UA (1) UA105944C2 (en)
WO (1) WO2011073646A1 (en)
ZA (1) ZA201204293B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9407414A (en) * 1993-09-07 1996-11-12 Procter & Gamble Compositions containing a non-steroidal propionic acid anti-inflammatory agent amino acid salt and at least one decongestant an expectorant an antihistamine and an antitussive
HUP9700654A2 (en) * 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
US6417206B1 (en) * 2001-01-26 2002-07-09 Medpointe Healthcare Inc. Antitussive/antihist aminic/decongestant compositions
JP2002308761A (en) * 2001-04-09 2002-10-23 Taisho Pharmaceut Co Ltd Antitussive agent for common cold
JP2003128549A (en) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd Composition applicable to mucous membrane
JP4377564B2 (en) * 2002-05-02 2009-12-02 ロート製薬株式会社 Composition for internal use
RU2311919C2 (en) * 2002-12-30 2007-12-10 Каунсел Оф Сайнтифик Энд Индастриал Рисерч Development of anti-coughing and throat softening herbal composition
US20040202677A1 (en) * 2003-04-10 2004-10-14 Hopkins Kevin J. Method of enhanced regional body fat reduction
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (en) * 2006-07-25 2008-01-30 안국약품 주식회사 Compositions for treating of cough
CN100518775C (en) * 2007-03-16 2009-07-29 邓丽菊 Medicine composition for treating cough and asthma and preparation thereof

Also Published As

Publication number Publication date
AU2010332494A1 (en) 2012-06-14
IL220383A0 (en) 2012-08-30
CO6541630A2 (en) 2012-10-16
NZ600243A (en) 2013-07-26
SG10201408377QA (en) 2015-02-27
AU2010332494B2 (en) 2015-01-15
CA2784214C (en) 2018-01-09
JP2013513651A (en) 2013-04-22
EP2512464A1 (en) 2012-10-24
GB0921805D0 (en) 2010-01-27
CA2784214A1 (en) 2011-06-23
ECSP12012132A (en) 2012-09-28
JP2016040279A (en) 2016-03-24
RU2564904C2 (en) 2015-10-10
ZA201204293B (en) 2013-02-27
PE20121537A1 (en) 2012-12-21
MX343222B (en) 2016-10-28
RU2012129839A (en) 2014-01-27
WO2011073646A1 (en) 2011-06-23
MX2012006625A (en) 2012-10-05
IL220383A (en) 2017-01-31
CN105816462A (en) 2016-08-03
SG181686A1 (en) 2012-07-30
UA105944C2 (en) 2014-07-10
CN102740843A (en) 2012-10-17

Similar Documents

Publication Publication Date Title
BR112012013148A2 (en) pharmaceutical formulation and use
ATE542815T1 (en) COCRYSTALS AND PHARMACEUTICAL COMPOSITIONS THEREOF
BRPI0807544A2 (en) PHARMACEUTICAL SOLID AND VACCINE DOSE
BRPI0916877A2 (en) pharmaceutical composition and administration thereof
CR10769A (en) IMPROVEMENTS IN AND RELATING TO DRIVE MECHANISMS SUITABLE FOR USE IN DRUG DELICERY DEVICES
NO20085420L (en) Pharmaceutical formulation with phenylephrine and preparations for absorption in the large intestine
BRPI1008045A2 (en) aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
CL2007002967A1 (en) CRYSTAL FORM A OF THE COMPOUND 4- [3- (4-CYCLOPROPANCARBONIL-PIPERAZIN-1-CARBONIL) -4-FLUORO-BENCIL] -2H-FTALAZIN-1-ONA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF A
BRPI1009324A2 (en) and / or pharmaceutically acceptable compounds thereof, pharmaceutical composition and their uses
BRPI1010621A2 (en) imidazoquinolinones derivative, their pharmaceutical composition and their use
BRPI1012246A2 (en) pharmaceutical composition containing a drug and sirna
EP2255804A4 (en) A pharmaceutical composition and the application thereof in the preparation of medicine for the treatment of cerebrovascular diseases
DK2464342T3 (en) Pharmaceutical formulation against drug abuse
ATE530546T1 (en) COCRYSTALS AND PHARMACEUTICAL COMPOSITIONS THEREOF
BR112013014189A2 (en) pharmaceutical composition comprising transcinamaldehyde and its use in the treatment of infections
BRPI1009392A2 (en) "pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation."
GB2443336B (en) Spiruchostatin analogues and their medicinal use
DE602008003816D1 (en) PHARMACEUTICAL SOLUTION PREPARATION WITH BENZAZEPINE AND MANUFACTURING METHOD THEREFOR
BRPI1006666A2 (en) "pharmaceutical composition and use of a pharmaceutical composition"
BR112012014161A2 (en) theobromine-based pharmaceutical composition and a decongestant and its use in the treatment of cough
BRPI0716754A2 (en) xanthoxylin-based composition and its use in cosmetics
ITRM20060367A1 (en) HNGF MUTEIN THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS
BRPI0812028A2 (en) plant extract and its therapeutic use
GB0921803D0 (en) Drug composition and its use in therapy
NO20085416L (en) Formulations with pulsed phenylephrine release and pharmaceutical preparations

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2494 DE 23-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.